Propanc Biopharma
$1.0300
14
+$0.01+0.98% Friday 19:59
-$0.03-3.11%Friday 23:48After hours
Statistics
Day High
1.04
Day Low
1.01
52W High
75.5
52W Low
0.99
Volume
5,066
Avg. Volume
-
Mkt Cap
2.35M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
14NovExpected
Q4 2020
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.45
-0.3
-0.15
-0
Expected EPS
N/A
Actual EPS
-0.0021
Financials
-Profit Margin
Unprofitable0Revenue
-58.92MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PPCB. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Show more...
CEO
James Nathanielsz
Employees
2
Country
Australia
ISIN
US74346N8002
Listings
0 Comments
Share your thoughts
FAQ
What is Propanc Biopharma stock price today?▼
The current price of PPCB is $1.03 USD — it has increased by +0.98% in the past 24 hours. Watch Propanc Biopharma stock price performance more closely on the chart.
What is Propanc Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Propanc Biopharma stocks are traded under the ticker PPCB.
Is Propanc Biopharma stock price growing?▼
PPCB stock has fallen by -23.7% compared to the previous week, the month change is a -12.71% fall, over the last year Propanc Biopharma has showed a -98.08% decrease.
What is Propanc Biopharma market cap?▼
Today Propanc Biopharma has the market capitalization of 2.35M
What were Propanc Biopharma earnings last quarter?▼
PPCB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Propanc Biopharma revenue for the last year?▼
Propanc Biopharma revenue for the last year amounts to 0 USD.
What is Propanc Biopharma net income for the last year?▼
PPCB net income for the last year is -58.92M USD.
How many employees does Propanc Biopharma have?▼
As of September 05, 2026, the company has 2 employees.
In which sector is Propanc Biopharma located?▼
Propanc Biopharma operates in the Health & Wellness sector.
When did Propanc Biopharma complete a stock split?▼
The last stock split for Propanc Biopharma was on May 18, 2026 with a ratio of 1:25.
Where is Propanc Biopharma headquartered?▼
Propanc Biopharma is headquartered in CAMBERWELL, VICTORIA, Australia.